Inhibition of multidrug-resistant Acinetobacter baumannii by nonviral expression of hCAP-18 in a bioengineered human skin tissue. - Wikidata - awgldk - TriplyDB

Inhibition of multidrug-resistant Acinetobacter baumannii by nonviral expression of hCAP-18 in a bioengineered human skin tissue.

Inhibition of multidrug-resistant Acinetobacter baumannii by nonviral expression of hCAP-18 in a bioengineered human skin tissue.

http://www.wikidata.org/entity/Q37328755

about

Topical antimicrobials for burn infections - an update Chimeric composite skin substitutes for delivery of autologous keratinocytes to promote tissue regeneration.Nonviral human beta defensin-3 expression in a bioengineered human skin tissue: a therapeutic alternative for infected wounds.A Bioengineered Human Skin Tissue for the Treatment of Infected Wounds.Clinical Evaluation of NIKS-Based Bioengineered Skin Substitute Tissue in Complex Skin Defects: Phase I/IIa Clinical Trial Results.Hydrophilic/hydrophobic characters of antimicrobial peptides derived from animals and their effects on multidrug resistant clinical isolates.Biscatecholate-monohydroxamate mixed ligand siderophore-carbacephalosporin conjugates are selective sideromycin antibiotics that target Acinetobacter baumannii Phase I/II clinical evaluation of StrataGraft: a consistent, pathogen-free human skin substitute Chimeric Human Skin Substitute Tissue: A Novel Treatment Option for the Delivery of Autologous Keratinocytes.Skin electroporation of a plasmid encoding hCAP-18/LL-37 host defense peptide promotes wound healing.Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models.Bioengineered human skin: working the bugs out.Non-viral gene delivery systems for tissue repair and regeneration.

P2860

Q33600002-DEED32B7-75A0-458F-9AC4-FEF3A6830848 Q34463274-5634158D-1F52-4763-97B6-C9D245E84084 Q35950558-5EAD294E-2EAA-455E-B141-9F930D443D15 Q36758284-D0A9B7F6-85C4-4307-8A34-6E7B85B0C38B Q36758303-C64EEC3F-1240-426E-8402-39E83C0BC165 Q36912403-55682817-1D20-4BE0-AD84-4F5FCDE783CE Q36949581-05045D70-E139-4208-9A2C-6421966AF9D4 Q37185549-779CD618-29BD-4475-B1D4-7CF2BC21F123 Q37338927-3D22821B-F69A-4853-8EBB-CB6098FE4254 Q37696015-2CFB1F1A-9500-48B4-8EF8-B998EC4AE5E8 Q38008459-96C50B2B-B736-45B6-B786-E297E7F00DA2 Q39505016-1732ED2C-BF41-4AA8-9D21-FCF76427E888 Q49962874-3EF41345-DC2D-4CE5-AFF5-D0CB458B0095

P2860

Inhibition of multidrug-resistant Acinetobacter baumannii by nonviral expression of hCAP-18 in a bioengineered human skin tissue.

http://www.wikidata.org/entity/Q37328755

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Inhibition of multidrug-resist ...... oengineered human skin tissue.

@en

Inhibition of multidrug-resist ...... oengineered human skin tissue.

@nl

type

label

Inhibition of multidrug-resist ...... oengineered human skin tissue.

@en

Inhibition of multidrug-resist ...... oengineered human skin tissue.

@nl

prefLabel

Inhibition of multidrug-resist ...... oengineered human skin tissue.

@en

Inhibition of multidrug-resist ...... oengineered human skin tissue.

@nl

P1433

Q37328755-E8F45B68-31DF-4152-B61C-B3C3E809B130

P1476

Q37328755-FA28289F-3120-4DC7-A834-D200CE11359B

P2093

Q37328755-09B6F076-AA82-467D-BD92-6FB3ED765EED

Q37328755-0DE262B0-2FB0-4F0F-8F8C-A3F35C3D5D06

Q37328755-208E2096-23EC-44D0-A885-88139E8324E1

Q37328755-48E0BCC9-9535-4EF9-AC26-78F373DAB969

Q37328755-6C98699F-9038-4A0D-9E9E-731D8EB078B6

Q37328755-75601715-082B-4DAB-B087-8897B33AED7B

Q37328755-7C41A70E-90F2-49E6-B9F4-1E807287B95A

Q37328755-8EE932BC-06DC-4212-B074-9D5AA7CF3DDD

Q37328755-9718CF49-D27C-44DF-B0F0-E5E1FF62E62B

Q37328755-A8C38184-CC9F-4009-85A4-26E6F94673E8

P2860

Q37328755-04C0CC63-B9AE-4C0D-B7AD-F93E1C54A75C

Q37328755-09F853BF-0D3E-46F8-A09C-E546D92510CE

Q37328755-0D1E8B71-6C49-4DA7-8ECD-4E1030B60191

Q37328755-0E1484FC-F046-46CB-A3CB-ACFAD4F3A5D7

Q37328755-0F3AE6C2-4713-4F5F-BBEF-5D5D348F0AC5

Q37328755-12323526-D88D-4806-B6DB-9A7D97B74956

Q37328755-158254F2-C0A4-4B44-A9D4-3B09BFB9AA86

Q37328755-181A4994-AE39-41D8-A4A3-DDA1B5D2CEC7

Q37328755-1C11C236-2710-426C-8EDC-AF3A020F446E

Q37328755-30AE0584-3567-41B8-8963-1F9F7C4067EB

P304

Q37328755-F0314390-E304-4EA8-9BEE-124361CC195B

P31

Q37328755-377A5ADB-479E-4A58-AC28-AF597166B426

P356

Q37328755-E27FF61C-20FE-4788-A67D-87388D72DE65

P433

Q37328755-C61FF35D-70AB-4764-ACCB-78D922A7BE5E

P478

Q37328755-89252498-2207-4832-BCCB-FB1D714880FF

P577

Q37328755-799A1247-CE62-4C85-9C90-30521573F9AF

P5875

Q37328755-A741FEAF-CDA4-4583-BD12-D0E33BEA5609

P698

Q37328755-97454C19-7795-4549-93EC-B3556A3AC246

P921

Q37328755-19F8733C-15B2-4A40-89AD-D8E683AC4FEC

Q37328755-1FE0DBFF-4881-4CF8-A0A0-83CD4EF93325

P932

Q37328755-6FACC549-5C5E-44B4-A2AF-0E64E2657AC7

P356

P1433

Molecular Therapy

P1476

Inhibition of multidrug-resist ...... oengineered human skin tissue.

@en

P2093

Andrea Szilagyi

http://www.w3.org/2001/XMLSchema#string

Angela L Gibson

http://www.w3.org/2001/XMLSchema#string

B Lynn Allen-Hoffmann

http://www.w3.org/2001/XMLSchema#string

Christina L Thomas-Virnig

http://www.w3.org/2001/XMLSchema#string

Colette E Johnston

http://www.w3.org/2001/XMLSchema#string

John M Centanni

http://www.w3.org/2001/XMLSchema#string

Kelly F Van Winkle

http://www.w3.org/2001/XMLSchema#string

Li-Ke He

http://www.w3.org/2001/XMLSchema#string

Lingjun Li

http://www.w3.org/2001/XMLSchema#string

Ravi Shankar

http://www.w3.org/2001/XMLSchema#string

P2860

Resistance in Nonfermenting Gram-Negative Bacteria: Multidrug Resistance to the Maximum

Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin

Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense

LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells

Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein

Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3

Antimicrobial peptides of multicellular organisms

Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence

LL-37, the only human member of the cathelicidin family of antimicrobial peptides

Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa

P304

562-569

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2008.289

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23974848

http://www.w3.org/2001/XMLSchema#string

P698

19190595

http://www.w3.org/2001/XMLSchema#string

P921

Acinetobacter baumannii

multiple drug resistance

P932

2736055

http://www.w3.org/2001/XMLSchema#string